koo, nope, it's a distant hope.

My hope is for a knock out result with rosuvastatin i.e. p way below 0.05% and then, given that we know the top line, I hope the atoravastatin is close to 95% e.g. p close to 0.05%

I also hope for some real strong data on at least 1 other subgroup important enough to have the FDA, EUDA or Chinese DA give at least conditional approval.

It's been 10 years for me and I'd like to see some tangible business opportunity soon.

We'll know soon.

Toinv